In its continued effort to please shareholders by narrowing its focus back to pharmaceuticals, Pfizer Inc. announced May 22 that it will shed its remaining 80% ownership of the animal health business that it spun out in February for $2.2 billion in returns.
While the move should not be a surprise to shareholders of either company, the timing was earlier than expected. Analysts had anticipated that Pfizer would wait at least 180 days...